Portable
Bring the exam to a medical office, clinic, or community health program.
Mexico license | Médica Los Ángeles
A fast, painless, radiation-free exam that helps healthcare professionals identify breast lumps within minutes and guide medical follow-up.

Differentiators
Portable, fast, and easy to integrate into medical offices, clinics, and health programs.
Bring the exam to a medical office, clinic, or community health program.
The evaluation is performed on the skin without pain for the patient.
Measures tissue changes without ionizing radiation.
Creates a tactile map and documentation within minutes.
Helps bring initial evaluation closer to more women.
Early detection
Finding an abnormality early allows medical evaluation and follow-up to begin sooner. iBreastExam helps bring that first step closer to more women.
View referenceCancer only affects the breast.
Cancer has spread to other parts of the body.

A trained professional performs iBreastExam within minutes, without pain or radiation. If the exam identifies an area of concern, the patient continues through the appropriate medical pathway.
Information by audience
Answers to care for your health, evaluate the technology, or bring it to your institution.
Learn how the exam works, what to expect, and what happens after a finding.
Get answersReview the mechanism, indicated use, technical profile, and clinical evidence.
Evaluate technologyRequest a demonstration and evaluate a program for your clinic or institution.
Request a demonstrationHow it works
During the exam, capacitive sensors measure tissue stiffness differences and create a tactile map that supports clinical evaluation.
A trained professional registers the patient and calibrates the device.
The professional moves the device across the breast without pain or radiation.
The system creates a pressure map and report that support clinical evaluation.

Technical profile
Institutional summary based on FDA 510(k) K190575. Confirm the exact Mexico unit model before final commercial materials.
This profile describes Gen II under FDA K190575; it does not communicate diagnosis or replace clinical studies.
Implementation
Médica Los Ángeles supports demonstrations, protocols, and program design for clinics and institutions in Mexico.
Align the population, sites, clinical leads, and follow-up pathway.
Review the mechanism, documentation, and required training.
Test the workflow with scheduling, staff, patients, and institutional follow-up.
Médica Los Ángeles is the authorized commercial channel for iBreastExam in Mexico.
iBreastExam is a portable device that helps healthcare professionals identify breast lumps and document tissue stiffness differences. The exam takes a few minutes, causes no pain, and uses no radiation.
iBreastExam works as a support tool within a clinical evaluation. It does not replace mammography, ultrasound, biopsy, or other studies a healthcare professional may recommend.
A trained healthcare professional performs the exam in a medical office, clinic, hospital, or institutional program with an established follow-up pathway.
The exam is performed on the skin, causes no pain, and uses no ionizing radiation. A trained professional guides the patient through the evaluation.
The scan is completed within a few minutes. Total time may include registration, preparation, explanation, and the steps defined by each institution.
iBreastExam Gen II creates a surface pressure map to document palpable lesions during a clinical breast exam. The professional interprets that information alongside the patient's evaluation.
The result should lead to professional medical assessment. Depending on clinical judgment, the patient may need additional examination, diagnostic imaging, follow-up, or specialist referral.
It may be considered by clinics, medical offices, community screening days, corporate health programs, detection campaigns, and institutional networks that want to bring initial evaluation closer to more women with a clear follow-up pathway.
No. iBreastExam is intended for use by trained professionals within a clinical evaluation.
Médica Los Ángeles holds the license to commercialize iBreastExam in Mexico. The product and technology belong to UE LifeSciences; local commercial operation for the country is handled by Médica Los Ángeles.
Clinical evidence
Global experience and clinical validation make it possible to evaluate iBreastExam with verifiable data and clear limits of use.
Global iBreastExam
UE LifeSciences
FDA 510(k) K190575
Clinical literature
Contact
Request information, a demonstration, or an implementation proposal for Mexico.